Navin Pinto

Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1–2 trial

Birgit Geoerger, Hyoung Jin Kang, Michal Yalon-Oren et al. · The Lancet Oncology · 2019 · 343 citations

Medicine, Oncology, Pharmacotherapy +17

Locoregional infusion of HER2-specific CAR T cells in children and young adults with recurrent or refractory CNS tumors: an interim analysis

Nicholas A. Vitanza, Adam Johnson, Ashley Wilson et al. · Nature Medicine · 2021 · 305 citations

Medicine, Neurosurgery, Oncology +17

Intraventricular B7-H3 CAR T Cells for Diffuse Intrinsic Pontine Glioma: Preliminary First-in-Human Bioactivity and Safety

Nicholas A. Vitanza, Ashley Wilson, Wenjun Huang et al. · Cancer Discovery · 2022 · 263 citations · Full text

Medicine, Immunology, Oncology +17

Rationale and Design of the Targeted Agent and Profiling Utilization Registry Study

Pam K. Mangat, Susan Halabi, Suanna S. Bruinooge et al. · JCO Precision Oncology · 2018 · 180 citations · Full text

Medicine, Oncology, Pharmacology +17

Racial and Ethnic Disparities in Risk and Survival in Children With Neuroblastoma: A Children's Oncology Group Study

Tara O. Henderson, Navin Pinto, Wendy B. London et al. · Journal of Clinical Oncology · 2010 · 140 citations · Full text

Medicine, Oncology, Cancer Epidemiology +16